<DOC>
	<DOCNO>NCT01037322</DOCNO>
	<brief_summary>There many anecdotal report improvement Inflammatory bowel disease ( IBD ) cannabis smoking . The effective anti inflammatory compound know today cannabidiol . cannabidiol extract cannabis plant , central effect fat soluble give drop oil . Doses 500mg cause side effect . The aim propose study examine double blind placebo control fashion effect cannabidiol disease activity patient IBD .</brief_summary>
	<brief_title>Cannabidiol Inflammatory Bowel Disease</brief_title>
	<detailed_description>Background : Inflammatory bowel disease ( IBD ) relatively common disease rise incidence . Treatment include various immunocompromising agent include corticosteroid , immunomodulators biologic agent . Current treatment always effective many side effect . Cannabinoids known anti inflammatory effect , probably via CB2 receptor . There many anecdotal report cannabinoids inflammatory disease rheumatoid arthritis , impression cannabinoids ameliorate effect IBD side effect negligible . However , placebo control trial human subject . The cannabis plant contain 600 ingredient , know active ingredient affect IBD . The effective anti inflammatory compound know today cannabidiol . Cannabidiol extract cannabis plant , central effect fat soluble give drop oil . Doses 500mg cause side effect . The aim propose study examine double blind placebo control fashion effect cannabidiol disease activity patient IBD .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>1 . Patients diagnosis IBD least 3 month recruitment eligible study . 2 . Patients active disease resistant either 5 ASA , steroids immunomodulators , receive drug due adverse reaction offer possibility receive cannabidiol dose 10 mg sub lingual drop drop olive oil placebo . 3 . Disease activity index either CDAI 200 Crohn 's disease Mayo score 3 UC . 4 . Age 20 . 1 . Patients know mental disorder 2 . Patients deem high risk abuse addiction study drug . 3 . Pregnant woman 4 . Patients sensitive ingredient study medication . 5 . Patients unable give inform consent . 6 . Patients may need surgery near future .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>crohn 's disease</keyword>
	<keyword>ulcerative colitis</keyword>
	<keyword>cannabis</keyword>
	<keyword>cannabidiol</keyword>
</DOC>